Abstract 17b-Estradiol (E 2 ) stimulates the mitogen-activated protein kinases (MAPKs) in various cellular types. We have shown that the hormone activates extracellular-regulated kinase (ERK) and p38 MAPK in skeletal muscle cells. However, the functions of MAPK modulation by the estrogen in muscle cells have not been studied yet. We have recently reported antiapoptotic actions of E 2 in C2C12 cells. Here, the role of MAPKs mediating the hormone effect in muscle cells was investigated. The results showed that cells exposed to 0 . 5 mM hydrogen peroxide (H 2 O 2 ) presented cytoskeleton disorganization, mitochondrial redistribution, and picnotic/ fragmented nuclei. Pretreatment with 10
Introduction
Skeletal muscle mass decreases with age by reduction in fiber number and atrophy of the remaining muscle fibers. Various mechanisms have been postulated mediating these events (Dean et al. 1997 , Chevion et al. 2000 including apoptosis (Dirks & Leeuwenburgh 2002) . Pathophysiological and certain physiological conditions demonstrate that apoptosis plays a key role in skeletal muscle cell loss (Sandri et al. 1995) . There is evidence demonstrating that sarcopenia involves an apoptotic mechanism and suggests that aged skeletal muscle is characterized by an increased rate of cell death by apoptosis (Dirks & Leeuwenburgh 2002) .
Diverse stimuli trigger apoptosis by activating intrinsic or extrinsic pathways, which converge in the activation of caspases (Steller 1995) . The hallmark of the intrinsic pathway is mitochondrial involvement ( Jiang & Wang 2000 , Saleh et al. 2000 . Cytochrome c and SMAC/DIABLO play key roles ensuring the activation of the apoptotic cascade (reviewed by Jiang & Wang (2004) ). These proteins are localized in the mitochondrial intermembrane space and are loosely attached to the surface of the inner membrane of the organelle. In response to a variety of apoptosis-inducing agents, they are released from mitochondria to the cytosol (Liu et al. 1996 , Reed 1997 . Cytochrome c triggers the apoptosome formation (Riedl & Salvesen 2007) and the antagonist function of SMAC/DIABLO on the inhibitor of apoptosis protein (Hu & Yang 2003) . It has been shown that SMAC/DIABLO is an important regulator of hydrogen peroxide (H 2 O 2 )-induced apoptosis in C2C12 skeletal muscle cells, activating caspase-3 and -9 ( Jiang et al. 2005) . The mitochondrial pathway is regulated by BCL2 proteins, which display either antiapoptotic (BCL2 or BCL-XL (BCL2L1)) or proapoptotic function (BAD, BAX or BID) . The activity of different proapoptotic BCL2 family members is controlled by distinct posttranslational modifications. BAD, a proapoptotic protein, is inactivated by phosphorylation, and then is sequestered in the cytosol by the 14-3-3 regulatory protein.
Apoptotic stimuli lead to its dephosphorylation and dissociation from 14-3-3 regulatory protein, allowing BAD to form a complex at the mitochondrial level resulting in cellular death (Yang et al. 1995 , Zha et al. 1996 , Lizcano et al. 2000 .
It is known that estrogens exert actions in skeletal muscle. Degenerative pathologies of the muscle mass, like sarcopenia, observed in menopausic women are due to decreased levels of estrogens (Dionne et al. 2000) . Accordingly, hormone replacement therapy promotes the growth and recovery of the muscular tissue (Dionne et al. 2000) . In agreement with these observations, skeletal muscle recovers its normal physiology after administration of 17b-estradiol (E 2 ) in ovariectomized rodents (Warren et al. 1996 , Kadi et al. 2002 . Likewise, other studies suggest that this hormone is important in the improvement of the muscular mass in cases of atrophy (McClung et al. 2006 , Sitnick et al. 2006 , and modulates the activity of myosin, a key protein in muscle contraction (Moran et al. 2007) . Importantly, data show that estrogen-based treatment in postmenopausal women beneficially affects muscle strength (Greising et al. 2009 ). Of relevance to this work, it has been reported that E 2 protects skeletal muscle against oxidative damage (Persky et al. 2000 , Tiidus 2005 , and we have recently demonstrated that the steroid hormone exerts antiapoptotic effects in the C2C12 muscle cell line upon exposure to H 2 O 2 or etoposide involving the phosphatidylinositol 3-kinase (PI3K)/AKT/ BAD pathway (Vasconsuelo et al. 2008) . Also, the antiapoptotic action of the steroid hormone has been reported in other tissues. For example, estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling, increasing the levels of phospho-AKT, inhibition of caspase-3 activation, and PARP cleavage (Gatson et al. 2009 ). Razandi et al. (2000) reported a rapid mechanism by which E 2 prevents chemotherapy or radiation-induced apoptosis of breast cancer, probably mediated through the plasma membrane estrogen receptor and regulating BCL2 family members. Nevertheless, the molecular mechanisms by which the hormone exerts antiapoptotic action in skeletal muscle cells are still poorly understood.
The mitogen-activated protein kinases (MAPKs) are an evolutionary conserved family of intracellular signaling molecules which have three major members: extracellular signal-regulated kinase (ERK1/2), p38 (p38a, p38b, p38g, and p38d) MAPK, and c-Jun N-terminal kinase, also known as stress-activated protein kinases (JNK1, JNK2, and JNK3). All MAPKs are activated by phosphorylation via different upstream MAPK kinases (MKKs or MEKs), and MKKs are activated by MAPK kinase kinases (MEKKs). While ERK is preferentially stimulated in response to growth factors, and regulates cell proliferation and differentiation, both JNK and p38 signaling pathways are responsive to stress stimuli, such as cytokines, u.v. irradiation, heat and osmotic shock, and are involved in cell differentiation and apoptosis (Pearson et al. 2001) . Recently, in the skeletal muscle cell line C2C12, we found that E 2 is able to induce a fast activation of ERK and p38 MAPK leading to the phosphorylation of Creb and Elk1 transcriptions factors (Ronda et al. 2007 ) through estrogen receptors, protein kinase C and SRC (A Ronda, C Buitrago & R Boland, unpublished observations).
This effect of the steroid on MAPKs has been observed in other cellular types (Razandi et al. 2000 , Manolagas & Kousteni 2001 . It has been demonstrated that MAPK family members can regulate apoptosis in different tissues. Specifically, activation of ERKs is mostly related to cell survival in response to several mitogenic factors, whereas the p38 MAPK pathway is required for apoptosis or survival depending on cell types and conditions (Wada & Penninger 2004) . Of relevance, Alexaki et al. (2006) have demonstrated that neuroprotective effects of E 2 involve the activation of ERK and p38 MAPKs. However, the participation of ERK and p38 MAPKs in the antiapoptotic action of E 2 on skeletal muscle cells has not been studied yet.
Given that E 2 exerts survival actions against apoptosis (Vasconsuelo et al. 2008) and is able to stimulate MAPKs in C2C12 cells (Ronda et al. 2007) , we hypothesize that both mechanisms are linked. Hence, the objective of the present work was to investigate the role of ERK and p38 MAPK in mediating protective effects in skeletal muscle cells. To this end, we used the murine skeletal muscle cell line C2C12 as an experimental model and H 2 O 2 as inducer of apoptosis. To study the involvement of MAPKs in the antiapoptotic action of the estrogen, we blocked the activation of ERK and p38 MAPK by using the specific inhibitors U0126 and SB203580 respectively, and silenced their expression by transfection of small interfering RNAs (siRNAs). In the present report, we demonstrated that the antiapoptotic action of E 2 on C2C12 skeletal muscle cells exposed to H 2 O 2 requires ERK and p38 MAPK activation.
Materials and Methods

Materials
Anti-actin (1:15 000 for western blot and 1:200 for immunocytochemistry) was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-phospho-AKT (Ser473) (1:1000), anti-phospho-BAD (Ser112) (1:1000), anti-SMAC/DIABLO (1:25), anti-ERK1/2 (1:1000), and anti-p38 MAPK (1:1000) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). 4 0 ,6-diamidine-2 0 -phenylindole dihydrochloride (DAPI) and MitoTracker Red (MitoTracker Red CMXRos) dyes, and Alexa Fluor 488-conjugated anti-rabbit secondary antibody (1:200) were purchased from Molecular Probes (Eugene, OR, USA). Cytochrome c oxidase assay kit and E 2 were purchased from Sigma-Aldrich. The compounds SB203580 and U0126 were purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA, USA). ERK and p38 MAPK siRNA, fluorescein-siRNA transfection control, and TransPass R2 transfection reagent were purchased from New England Biolabs (NEB; Beverly, MA, USA). All the other reagents used were of analytical grade.
Cell culture and treatment C2C12 murine skeletal muscle cells, kindly donated by Dr Enrique Jaimovich (Universidad de Chile, Santiago, Chile), were cultured in growth medium DMEM supplemented with 10% heat-inactivated (30 min, 56 8C) fetal bovine serum, 1% nystatine, and 2% streptomycin. Cells were incubated at 37 8C in a humid atmosphere of 5% CO 2 in air. Cultures were passaged every 2 days with fresh medium. Under these conditions, C2C12 myoblasts resemble the activated satellite cells that surround the mature myofibers and proliferate and differentiate participating in the repair of the tissue when a cellular injury exists (Yoshida et al. 1998) . The assays were performed with 70-80% confluent cultures (120 000 cells/cm 2 ) in medium without serum for 30 min. During this preincubation, cells were exposed to 10 mM U0126 or 20 mM SB203580 in the experiments indicated. The doses of the compounds used were the most effective to inhibit both MAPKs in C2C12 cells (Ronda et al. 2007) . The inhibitors were dissolved in dimethyl sulfoxide (DMSO) at a final concentration of 0 . 1% (v/v) and 0 . 2% (v/v) respectively. Also, as control, it was verified that DMSO, applied to the myoblasts at the same concentration used in these experiments, did not interfere with the effects of E 2 on apoptotic C2C12 cells. Treatments were carried out by adding 10 K8 M E 2 or vehicle (control: 0 . 001% isopropanol) during 45 min before the induction of apoptosis with 0 . 5 mM of H 2 O 2 for 2-3 h.
Unless otherwise noted, cells were cultured to 50% confluence in chamber slides for microscopy.
Janus Green staining
The supravital Janus Green colorant is a water-soluble dye that is absorbed by the whole cell, staining in a blue-greenish coloration (oxidative state). Nevertheless, this tint disappears in the cytoplasm a few minutes later due to the reductive properties of the cytosol, except in the mitochondria, seen as little dots, where the oxidative environment of the organelle maintains the Janus Green colorant in its oxidative state (blue-greenish coloration; Lazarow & Cooperstein 1953 , Ernster & Schatz 1981 . Janus Green staining can indirectly indicate mitochondrial dysfunction, since any rupture/ disruption of the mitochondrial membrane cause the release of their content to the cytosol inducing colorant oxidation in the cytoplasm. After treatments, the cells were incubated with 0 . 1% Janus Green in serum-free medium (1:2, v/v) during 30 min at 37 8C. Cells were examined by bright field microscopy.
MitoTracker Red and DAPI staining
After treatments, coverslips with adherent cells were stained with MitoTracker Red, which was prepared in DMSO and then added to the cell culture medium at a final concentration of 1 mmol/l. After 15-30-min incubation at 37 8C, the cells were washed with PBS (pH 7 . 4, 8 g/l NaCl, 0 . 2 g/l KCl, 0 . 24 g/l KH 2 PO 4 , and 1 . 44 g/l Na 2 HPO 4 ) and fixed with methanol at K20 8C for 30 min. For DAPI staining, fixed cells were incubated for 30 min at room temperature in darkness with 1:500 of a stock solution of DAPI (5 mg/ml) and washed with PBS. One hundred nuclei were counted for each condition, and apoptotic nuclei were identified as those with reduction in its size (picnosis) or its fragmentation. The percentage of apoptotic nuclei is shown in a graph.
Cells were examined using a fluorescence microscope (NIKON Eclipse Ti-S) equipped with standard filter sets to capture fluorescent signals, and images were collected using a digital camera. Also, samples were analyzed with a confocal scanning laser microscopy (Leica TCS SP2 AOBS microscope), using a 63! objective.
Immunocytochemistry
Semi-confluent monolayers were fixed as before. After fixation, cells were rinsed three times with PBS, and nonspecific sites were blocked for 1 h in 2% BSA. Cells were incubated with appropriate primary antibodies overnight at 4 8C. The primary antibodies were recognized by fluorophore-conjugated secondary antibodies. Finally, the stained cells were analyzed with a conventional fluorescence microscope or confocal scanning laser microscopy. The specificity of the labeling techniques was proven by the absence of labeling when the primary or the secondary antibodies were omitted.
Western blot analysis
Cells from 70 to 80% confluent cultures (120 000 cells/cm 2 ) were lysed using a buffer made of 50 mM Tris-HCl, pH 7 . 4, 150 mM NaCl, 0 . 2 mM Na 2 VO 4 , 2 mM EDTA, 25 mM NaF, 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 mg/ml leupeptin, and 20 mg/ml aprotinin. Lysates were collected by aspiration and centrifuged at 12 000 g for 15 min. The protein content of the supernatant was quantified by the Bradford procedure (Bradford 1976) . Then, lysate proteins dissolved in Laemmli (1970) sample buffer (30 mg; ca. 2 000 000 cells) were separated on 10% SDS-polyacrylamide gels and electrotransferred to polyvinylidene difluoride membranes. Relative migration of unknown proteins was determined by comparison with molecular weight colored markers (Amersham). Membranes were blocked 1 h at room temperature in PBS-T buffer (PBS 0 . [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] containing 5% dry milk. Membranes were incubated with different primary antibodies overnight at 4 8C, then washed three times in PBS-T and incubated in PBS-T containing 1% dry milk with peroxidase-conjugated secondary antibodies for 1 h at room temperature. Next, membranes were visualized using an enhanced chemiluminescent technique according to the manufacturer's instructions. Images were obtained with a GS-700 Imaging Densitomer from Bio-Rad by scanning at were incubated in stripping buffer twice (62 . 5 mM Tris-HCl, pH 6 . 8, 2% SDS, and 50 mM mercaptoethanol) for 30 min at 55 8C, washed for 10 min in PBS-T, and then blocked and blotted as described above.
Measurement of outer mitochondrial membrane integrity
The integrity of outer mitochondrial membranes was evaluated by measuring cytochrome c oxidase activity using a commercially available kit from Sigma (CYTOC-OX1) according to the manufacturer's instructions. Briefly, C2C12 cells from 70 to 80% confluent monolayers (120 000 cells/cm 2 ) were scrapped and homogenized in ice-cold TES buffer (50 mM Tris/HCl, pH 7 . 4, 1 mM EDTA, 250 mM sucrose, 1 mM dithiothreitol, 0 . 5 mM PMSF, 20 mg/ml leupeptin, 20 mg/ml aprotinin, and 20 mg/ml trypsin inhibitor) using a Teflon-glass hand homogenizer. Lysates were centrifuged at 10 000 g for 20 min in order to separate the cytosolic fraction. For cytochrome c oxidase activity measurements, 50 ml of reduced cytochrome c (0 . 22 mM) were added to 30 ml of the lysate (ca. 3 000 000 cells), and changes in absorbance at 550 nm were monitored for 1 min. The percentage of cytochrome c activity was calculated using: Units/mlZDAbs/min 
Transfection of siRNA
Transfection was performed with a culture cellular density reaching 40-60% confluence with ERK or p38 MAPK siRNA according to the manufacturer's instructions. Briefly, TransPass R2 Transfection Reagent was mixed with each siRNA in serum-free medium. The mix was incubated for 20 min at room temperature. The culture medium of the cells was aspirated and replaced with the diluted transfection complex mixture. Cells transfected were used in the indicated assays.
Statistical analysis
Results are shown as meansGS.E.M. Statistical differences among groups were determined by ANOVA followed by a multiple comparison post hoc test (Scott & Knott 1974) . Data are expressed as significant at P!0 . 05.
Results
ERK and p38 MAPKs mediate the antiapoptotic effects of E 2 in muscle cells
As a first approach to investigate the contribution of MAPKs to the protective role of estrogens in skeletal muscle cells, morphological characteristics due to apoptosis such as changes in cytoskeleton, mitochondria, and nucleus were studied in C2C12 cells. Regarding the cytoskeleton, images from immunocytochemistry assays performed after treatments using anti-actin antibody (Fig. 1A) show an usual organization of actin filaments in the control condition (panel a) and in cells treated with E 2 (10 K8 M) (panel b). When the cultures were exposed to 0 . 5 mM H 2 O 2 during 2 h, disorganization of the cytoskeleton was observed (panel c). C2C12 cells incubated with the hormone 45 min prior to the induction of apoptosis showed actin arrangement similar to that observed in control conditions (panel d). However, disruption of actin filaments by H 2 O 2 was not reversed by the estrogen in cells treated in the presence of U0126 or SB203580 (panels e and f). During apoptosis, mitochondria also undergo changes in structure and localization. The alterations frequently observed are picnosis, reduction in size, and grouping of these organelles in the perinuclear zone (Desagher & Martinou 2000 , Vasconsuelo et al. 2008 . Figure 1B shows that a high proportion (w70%) of mitochondria from cultured C2C12 (Vasconsuelo et al. 2008) . When cultures were preincubated with U0126 or SB203580 and then treated with the estrogen and H 2 O 2 , mitochondria showed similar abnormalities in intracellular distribution than in apoptotic C2C12 cells (panels e and f). Also, we observed picnosis and reduced size of mitochondria by confocal microscopy in cells exposed to H 2 O 2 or to the hormone and the oxidative stimuli in the presence of MAPK inhibitors (data not shown). Next, changes in morphology of nuclei from C2C12 cells treated under the different experimental conditions described above were investigated using the specific nuclear dye DAPI. Apoptotic cells were identified by the condensation and/or fragmentation of their nuclei (indicated with white arrows). In Fig. 1D , the results are expressed as percentage of apoptotic cells. Figure 1C shows intact/normal nuclei of the cells in the control condition (panel a), and treated with 10 K8 M E 2 (panel b). The cultures exposed to 0 . 5 mM of H 2 O 2 exhibited the typical apoptotic morphological changes in w60% of nuclei consisting in nuclear fragmentation or condensation as shown in Fig. 1D ; typical pyknotic nuclei corresponding to these observations are shown in Fig. 1C (panel c). This effect was not observed in cells incubated with the hormone during 45 min prior to the exposure to H 2 O 2 , which presented mostly normal nuclear morphology (w15% apoptotic nuclei) (panel d). These results are in accord with our recent work (Vasconsuelo et al. 2008) . However, when the cultures were treated with MAPK inhibitors followed by the hormone and H 2 O 2 , as before, the cells showed nuclear fragmentation or condensation (w45% and w35% for U0126 or SB203580 respectively) (panels e and f; Fig. 1D ). Of relevance, using a similar experimental approach, we observed that E 2 also prevents via MAPKs the apoptotic morphological changes in cytoskeleton, mitochondria, and nucleus induced by H 2 O 2 in primary cultures of mouse skeletal muscle cells (data not shown).
Although the use of U0126 and SB203580 is an effective tool to inhibit ERK and p38 MAPK activation respectively, it was considered of importance to exclude the possibility that these inhibitors were inductive of apoptosis per se in our cellular cultures. The effect of each inhibitor during at least 5 h was evaluated on the structure of mitochondria and nuclei, and we found that each inhibitor did not induce the apoptotic changes described before (data not shown).
ERK and p38 MAPKs play a role in the protective effects of E 2 on mitochondrial membrane integrity in muscle cells
In the intrinsic pathway of apoptosis, different signals lead to alterations/loss of mitochondrial membrane permeability with the subsequent release of proapoptotic factors such as cytochrome c (Liu et al. 1996) and SMAC/DIABLO (Shiozaki & Shi 2004) . E 2 inhibits the rupture of the outer mitochondrial membrane which prevents cytochrome c release (Vasconsuelo et al. 2008) . With the aim to study the role of ERK and p38 MAPK in E 2 -induced mitochondrial membrane protection, firstly, functional changes of mitochondria were evaluated using supravital Janus Green staining. The images in Fig. 2A show that C2C12 murine muscle cells exposed to 0 . 5 mM H 2 O 2 during 2 h (panel c) exhibited a darker blue-greenish coloration in all the cytoplasm than the control (panel a) or cells treated with 10
K8 M E 2 (panel b), where mitochondria appear as little blue-greenish dots with cytoplasmic distribution and around the nucleus. These results indicate that rupture of the mitochondrial membrane by H 2 O 2 caused liberation of its content to the cytoplasm, inducing the oxidation of the colorant. Black arrows in the figure indicate the oxidation of the colorant in the cytoplasm (blue-greenish coloration) due to the liberation of mitochondrial content (Ernster & Schatz 1981) . This effect was not observed when C2C12 cells were preincubated with the hormone (10 K8 M -45 min) prior to H 2 O 2 treatment (panel d). However, when the muscle cells were exposed to the ERK or p38 MAPK inhibitors (U0126 and SB203580 respectively), and then to E 2 and H 2 O 2 , Janus Green oxidation in the cytoplasm was observed again (black arrows in panels e and f).
To confirm the effects of the hormone on mitochondrial membrane integrity, we measured cytochrome c oxidase activity in the cytosolic fraction and SMAC/DIABLO release in the presence and in the absence of MAPK inhibitors. The results of cytochrome c oxidase activity assays shown in Fig. 2B indicate that H 2 O 2 increases mitochondrial damage which is blocked by pre-incubation of the cells with E 2 as observed before (Vasconsuelo et al. 2008) . Interestingly, the hormone was unable to exert protective effects at the mitochondrial level when ERK and p38 MAPKs were inhibited. To strengthen these findings, we evaluated the mitochondrial functional status in C2C12 cells transfected with specific siRNAs to induce silencing of each MAPK. Optimum transfection conditions were established using fluorescein siRNA (R80% after 24-h incubation with 20 pmol of fluorescent probe; Fig. 2C ). To verify silencing efficiency, we examined the expression levels of ERK and p38 MAPKs after transfection with siRNAs (24 h with 30/40 pmol for ERK siRNA and 50/80 pmol for p38 MAPK siRNA). Figure 2D (upper and middle panels) reveals that each siRNA probe led to a significant suppression in the levels of both MAPK proteins. The siRNAs used were highly specific. As a scramble control (Scr), we employed the fluorescein-siRNA probe of the kit (chemically synthesized 21-bp RNA which has no sequence identity to any mammalian sequences) and blockage of ERK or p38 MAPK protein levels was not observed (Fig. 2D, lower  panel) . Under these conditions, we investigated cytochrome c oxidase activity as before and obtained similar results than using specific inhibitors (Fig. 2E) . SMAC/DIABLO location under the above experimental condition was investigated by immunocytochemical assays using an antibody against SMAC/DIABLO (green fluorescence) and staining mitochondria with Mitotracker probe (red fluorescence). The images obtained by confocal microscopy presented in Fig. 3 show that in control C2C12 cells (panel a) or treated with the hormone (panel b), SMAC/DIABLO was located exclusively within mitochondria, demonstrated by the mixture of fluorescences in yellow color (merge). Exposure of cultures to 0 . 5 mM H 2 O 2 during 2 h promoted SMAC/DIABLO release from mitochondria (panel c); this effect was reversed in cells preincubated with E 2 (10 K8 M -45 min) (panel d). When ERK and p38 MAPKs were inhibited using U0126 or SB203580, as before, the estrogen did not prevent SMAC/ DIABLO liberation (panels e and f).
E 2 regulates the PI3K/AKT/BAD pathway through ERK and p38 MAPK in muscle cells
We have recently shown that E 2 is able to activate the PI3K/AKT pathway which modulates BAD phosphorylation, and thereby, the hormone can prevent apoptosis induced by H 2 O 2 in C2C12 skeletal muscle cells (Vasconsuelo et al. 2008) . In view that ERK and p38 MAPKs participate in the antiapoptotic effects of the hormone, we next examined the role of both MAPKs in AKT and BAD phosphorylation stimulated by the estrogen in the presence of U0126 and SB203580 inhibitors. The western blot analysis from Fig. 4A shows that E 2 induces AKT phosphorylation both in the absence or in the presence of H 2 O 2 as reported before (Vasconsuelo et al. 2008) . However, when the cells were preincubated with ERK inhibitor (U0126) or p38 MAPK inhibitor (SB203580), the hormone was not able to stimulate AKT phosphorylation. Phospho-AKT inactivates BAD in C2C12 muscle cells by the phosphorylation of its Ser136 residue (Vasconsuelo et al. 2008) . It is also known that the proapoptotic protein BAD can be inhibited by phosphorylation at serine 112 (Ser112) by ERK (Fang et al. 1999 , Shimamura et al. 2000 , therefore the role of each MAPK in the inactivation of BAD through this particular residue was investigated. Incubation of the cells with the hormone (10 K8 M -45 min) prior to treatment with the oxidative stimuli increased the phosphorylation of this proapoptotic protein. When the inhibitors of MAPKs were used, this effect of the hormone was blocked (Fig. 4B) .
Discussion
Rapid signaling cascades triggered by E 2 regulate various cellular processes such as differentiation, proliferation, and even apoptosis (Razandi et al. 2000 , Manolagas & Kousteni 2001 . Particularly, MAPKs are key components modulating these events (Pearson et al. 2001) . In cellular death, it has been demonstrated that ERK activation is related to cell survival in response to mitogenic factors, while stimulation of p38 MAPK has been associated with the promotion of apoptosis (Wada & Penninger 2004) . The results presented here provide evidence demonstrating the contribution of both ERK and p38 MAPKs to the protective effects of E 2 in H 2 O 2 -induced apoptosis in the C2C12 muscle cell line. Thus, in the presence of ERK and p38 MAPK inhibitors, U0126 and SB203580 respectively, the hormone could not prevent the characteristic alterations observed in C2C12 cells during apoptosis consisting in disorganization of actin filaments, changes in mitochondrial intracellular distribution, and nuclear condensation/fragmentation. In agreement with our results, it has been observed in neuronal cells that ERK and p38 MAPKs mediate the antiapoptotic effects of E 2 (Alexaki et al. 2006) .
The proapoptotic member of the BCL2 family, BAD, is inactivated by phosphorylation at its four serine residues (112, 136, 155, and 170) , and is then sequestered in the cytosol by the 14-3-3 protein. In response to an apoptotic stimulus, BAD is dissociated from 14-3-3 protein by dephosphorylation, which enables it to form a complex with proapoptotic members in mitochondria leading to cellular death (Yang et al. 1995 , Zha et al. 1996 , Lizcano et al. 2000 . Several signaling cascades can promote the phosphorylation and inactivation of BAD, one of them is the PI3K/AKT pathway (Downward 2004) . We have previously demonstrated that E 2 exerts its protective effects by activating PI3K/AKT and in turn BAD phosphorylation at Ser136 in C2C12 cells (Vasconsuelo et al. 2008) . Fernando & Wimalasena (2004) also reported that the PI3K/AKT/BAD pathway mediates the antiapoptotic action of E 2 in breast cancer cells. In these studies, we investigated whether the activation of MAPKs by E 2 was implicated in such mechanism. We found that the estrogen could not induce AKT and BAD (Ser112) phosphorylation when the MAPKs were inhibited using U0126 or SB203580 compounds. This fact suggests that the ERK and p38 MAPK signaling pathways are involved in AKT stimulation induced by the steroid. 
10
K8 M 17b-estradiol with or without 10 mM U0126 or 20 mM SB203580. Cell lysates were prepared and subjected to western blot analysis using anti-phospho-AKT (A) and anti-phospho-BAD (Ser112) (B) antibodies. Total actin levels were measured as protein loading control. Blots are representative of three independent experiments. Densitometric quantification of blots is shown.
Averages GS.E.M. are given; *P!0 . 05 respect to the control. Accordingly, in hepatic cells, it has been verified that AKT activation is modulated by the estrogen via ERK acting on PTEN levels . In addition, p38 MAPK is a positive regulator of AKT activation inhibiting the neutrophil apoptotic process (Rane & Klein 2009 ). Generally, BAD phosphorylation in Ser136 is associated with PI3K-AKT activity, whereas BAD phosphorylation in Ser112 is related with an action of ERK through the phosphorylation of RSKs (Zhu et al. 2002 , Ahn et al. 2009 ). In these studies, the fact that U0126 and SB203580 inhibitors abrogated AKT and BAD (Ser112) phosphorylation modulated by E 2 suggests a new mechanism for muscle cells, in which hormone activation of MAPKs may alternatively phosphorylate BAD (Ser112) via AKT. Interestingly, it has been reported in L6 myotubes that BAD (Ser112) phosphorylation induced by insulin is mediated to a greater extent by the PI3K/AKT pathway rather than the ERK-RSK pathway (Gao et al. 2008) . However, the possibility that the estrogen may regulate BAD (Ser112) phosphorylation through an effect of ERK-RSK pathway cannot be definitely excluded by the present experiments. Clearly, further studies are necessary in order to understand the estrogen survival signaling mechanism that involves MAPK and AKT/BAD pathways.
Mitochondria play an important function in the regulation of apoptotic events (Desagher & Martimou 2000 , Lu et al. 2007 . We have previously shown that they are key cellular sites modulating the protective action of E 2 in skeletal muscle cells (Vasconsuelo et al. 2008) . These observations are supported by the fact that the mitochondria of these cells express estrogen receptors suggesting that this organelle could be a target for the hormone . In agreement with this interpretation, a central role for mitochondria has been demonstrated in the protective effects of the estrogen in neuronal cells (Simpkins et al. 2005) . In this work, the use of the MAPK inhibitors, U0126 and SB203580, demonstrated that the hormone preserves the mitochondrial membrane integrity through an ERK and p38 MAPK -dependent mechanism. This observation was confirmed when ERK and p38 MAPKs were blocked with specific siRNAs, and then, E 2 was not able to protect mitochondrial membrane integrity against apoptotic stimuli. As mentioned before, it is well established that loss of mitochondrial membrane integrity during apoptosis results in release of proapoptotic factors into the cytosol such as SMAC/DIABLO (Shiozaki & Shi 2004) . The fact that E 2 could not prevent H 2 O 2 -induced SMAC/DIABLO liberation in the presence of U0126 and SB203580, strengthen our hypothesis that the beneficial role of the hormone on mitochondria stability is mediated by the modulation of the ERK and p38 MAPK signaling pathways. These events together with the fact that E 2 induces BAD inactivation by phosphorylation in Ser136 (Vasconsuelo et al. 2008) and Ser112 (this work), suggest a relevant effect of the hormone blocking the intrinsic apoptotic cascade. A possible action of E 2 on extrinsic apoptotic pathways should also be taken into account in future investigations.
Finally, the results presented in this work suggest that the hormone plays a role in the survival of satellite myoblasts associated with the myofibers. Accordingly, it has been reported that apoptosis exerts a control on the relative proportion of the myoblast and myotube pools in skeletal muscle (Sandri & Carraro 1999 , Marzetti & Leeuwenburg 2006 . Our data expand the knowledge about the antiapoptotic molecular mechanism activated by E 2 via ERK and p38 MAPK (Fig. 5) . Clearly, more studies are necessary to fully characterize the antiapoptotic action of E 2 on skeletal muscle. The elucidation of such mechanism may provide useful insights for understanding the etiology of sarcopenia associated with the deregulation of estrogen levels.
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